Piper Jaffray Hosts 17th Annual Health Care Conference in New York

Piper Jaffray Hosts 17th Annual Health Care Conference in New
York 


NEW YORK, Jan. 19  /PRNewswire-FirstCall/ -- Piper Jaffray & Co. is pleased to
host its 17th Annual Health Care Conference Tuesday-Thursday, Jan. 25-27 in New
York. This year's conference will feature presentations from over 120 of the
most highly regarded and influential public company management teams in the
biotechnology, specialty pharmaceuticals, health care facilities, drug
discovery, medical technology, medical diagnostics and devices and health care
services sectors. In addition, more than 50 of the leading late-stage private
companies in the health care universe will present.

Highlighting the conference will be five separate panels and special
presentations addressing high-profile issues affecting the entire health care
industry, including:

  1.  Spine Panel: Artificial Discs and the Future of Fusion
      The panel will be comprised of three leading physicians and
      researchers, including John Sherman, M.D., Thomas Errico, M.D. and
      Terry Corbin. They will discuss artificial discs, the newest spine
      technology, focusing on how this new technology will fit as a
      substitute or complement to existing fusion products.

  2.  Current and Future Trends in Orthopedics
      Rich Seldes, M.D., orthopedic surgeon and director of orthopedics at
      North Shore University Hospital in Forest Hills, N.Y., Maryellen
      Keenan, operating room business manager at the Hospital for Special
      Surgery, and Richard Laskin, M.D., co-chief of the Knee Service:
      Hospital for Special Surgery and professor of orthopedic surgery at
      Weill Medical College of Cornell University, will lead a discussion on
      current and future trends in orthopedics.

  3.  FDA Perspectives on Drug Development
      Steven Galson, M.D., MPH, acting director of the Center of Drug
      Evaluation and Research and the FDA, will lead a discussion on the FDA
      perspectives on drug development.

  4.  Tomorrow's Role for Molecular Diagnostics
      This panel features Ron McGlennen, M.D., president of Access Genetics,
      Doug Harrington, M.D., chief executive officer of Specialty
      Laboratories, Dr. Thomas White, chief scientific officer of Celera
      Diagnostics and Gail Page, president of Ciphergen Diagnostics, will
      lead a discussion on the future of molecular diagnostics with regard
      to medical conditions/markers, technologies and providers.

  5.  "Blocking and Tackling" of Consumer-Directed Health care
      This panel will be comprised of four executives who are helping to
      drive the many changes necessary to meet the needs of a
      consumer-driven health care system.  Accordingly, this panel will
      explore the multitude of operational, technological and financial
      changes necessary to seamlessly deliver a consumer-directed health
      care product, like today's Health care Savings Accounts (HSAs). The
      panel will be comprised of: Robert Patricelli, chairman and chief
      executive officer, Evolution Benefits; Bill Barr, executive vice
      president, Health Plan Operations, The Regence Group; Tony Bellomo,
      executive vice president, The Trizetto Group and Bradley Engel,
      national health and welfare product leader, Mellon.




Company and investor participation for the Piper Jaffray Health Care Conference
is by invitation only. Clients interested in attending should contact their
Piper Jaffray representative. Members of the media who would like to attend
should contact Susan Beatty at [phone] or .

Piper Jaffray & Co. is the chief operating subsidiary of Piper Jaffray
Companies (NYSE:PJC), a focused securities firm dedicated to delivering
superior financial advice, investment products and transaction execution within
selected sectors of the financial services marketplace.  The company operates
through two primary revenue-generating segments: Capital Markets and Private
Client Services.  Investment Research, an independent group reporting to the
CEO, supports clients of both segments.  Piper Jaffray & Co. has served
corporations, government and non-profit entities, institutional investors and
the financial advisory needs of private individuals since 1895.  Headquartered
in Minneapolis, Piper Jaffray has approximately 3,000 employees in 111 offices
in 23 states across the country and in London. For more information about Piper
Jaffray, visit us online at http://www.piperjaffray.com/ .

Since 1895. Member SIPC and NYSE. 

DATASOURCE: Piper Jaffray & Co.



CONTACT:  Susan Beatty, Media Relations of Piper Jaffray & Co.,

[phone]



Web site:  http://www.piperjaffray.com/ 

Copyright